In This Section

3rd ADDC/ASPET Academic Drug Discovery Colloquium

ADDC/ASPET Academic Drug Discovery Colloquium - Introducing the Next Generation of Drug Hunters - May 19-20, 2024 Arlington VA

Introducing the Next Generation of Drug Hunters

May 19 - 20, 2024
Hyatt Regency Crystal City, Arlington, VA

REGISTER NOW

View Abstract Proceedings Book

Team science starts here. 

Meet your future collaborators in drug discovery. Be a part of the Colloquium that bridges today’s research discoveries to tomorrow’s therapies. 

Join ASPET and the Academic Drug Discovery Consortium (ADDC) as they host the 3rd Academic Drug Discovery Colloquium on May 19-20, 2024, in the Washington DC metropolitan area.

Pharmacologists, medicinal chemists, drug discovery scientists, in vitro/in vivo scientists, DMPK experts, trainees and scientists from industry, academia, contract research organizations, biotech, pharma, research institutes, accelerators/incubators, foundations and government with an interest in drug discovery area are all welcome to this colloquium Introducing the Next Generation of Drug Hunters.


Abstracts

Abstract submissions are closed.

View the Abstract Proceedings Book and Index of Posters

The Colloquium includes poster presentations to help introduce the next generation of drug hunters. Link to information on abstract submission policies.

While submitting an abstract for the ASPET Annual Meeting, attendees could choose to submit the same abstract for the 3rd ADDC/ASPET Academic Drug Discovery Colloquium, which will be held from May 19-20, 2024 in Arlington, VA directly after the ASPET Annual Meeting. The abstract submission period has ended.

Schedule at a Glance

Sunday, May 19

Focus: Making a Better Molecule

3:00 pm – 3:10 pm | Welcome

3:10 pm – 3:50 pm | Building Better p97 / VCP Inhibitors to Treat Cancer

Keynote: Donna Huryn, PhD, University of Pennsylvania

3:50 pm – 5:10 pm | Sessions

3:50 pm – 4:10 pm
Bill Messer, Univ of Toledo
Allosteric modulation of Neurotransmitter Efficacy in Drug Development for Neurological Disorders

4:10 pm – 4:30 pm
Jay Wright, Univ of Michigan
Expanding Radiochemical Space with New Radiolabeling Reactions

4:30 pm – 4:50 pm
Corey Hopkins, University of Nebraska Med Ctr and Sumaiya Nahid, University of Nebraska
Discovery of GIRK ½ Activators as Non-opioid Analgesics

4:50 pm – 5:10 pm
Aleksey Gerasyuto, Schroedinger Therapeutics Group
The Predict-First Paradigm: How Digital Chemistry is Shaping the Future of Drug Discovery

5:15 pm – 7:15 pm | Poster Presentation & Reception

Monday, May 20

Focus: Understanding Drug Action

8:30 am – 8:35 am | Introduction

8:35 am – 9:15 am | Keynote: Richard R. Neubig, MD, PhD, Michigan State University
From the Membrane to the Nucleus, A Drug Discovery Journey

9:15 am – 9:55 am | Sessions

9:15 am - 9:25 am
Shubhra Saha, NIH
Activation of PTH1 Receptor using Chimeric Peptide Templated in situ Click Reaction of Nanobody Conjugates

9:25 am – 9:35 am
Kir Snyder, NIH
Discovery, Characterization, and Optimization of a Novel Positive Allosteric Modulator-Antagonist of the D3 Dopamine Receptor

9:35 am – 9:55 am
Wei Wang, Univ Arizona
Control Activities of PROTACs by Bioorthogonal Chemistry

Mengyang Chang, Univ Arizona
Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation

9:55 am – 10:15 am | Sponsor Highlight
Peter Gedeck, CDD
Accelerating Research and Collaboration with CDD Vault: Your Unified Platform for Scientific Truth

10:15 am – 10:55 am | Sponsor Networking Break

Focus: Transitioning from Academia to Biotech

10:55 am – 11:00 am | Introduction
11:00 am – 12:20 pm | Sessions

11:00 am – 11:20 am
Harshini Neelakantan, Ridgeline Therapeutics
Insights from an Uncovered Path to Biotech from Academia

11:20 am – 11:40 am
Patrick Hagan, Sanford Burnham/Camino
Discovery and Development of Novel Autophagy Inhibiting ATG13 Degrading Compounds

11:40 am – 12:00 pm

Andrew J. Storaska, Rothwell Figg

Navigating the IP Space as an Academic Researcher

 

12:00 pm – 12:20 pm
Matthias Bütikofer, ETH Zurich
Ultrafast Fragment Screening and Affinity Determination using Photo-Boosted NMR

12:20 pm – 1:50 pm | Lunch and Sponsor Networking

Focus: Disease Biology informs Therapeutic Discovery

1:50 pm – 1:55 pm | Introduction
1:55 pm – 3:15 pm | Sessions

1:55 pm – 2:15 pm
Godwin Dziwornu, Univ. of Cape Town
The Antibiotic Fusidic Acid Targets Elongation Factor G in Mycobacterium Tuberculosis

2:15 pm – 2:35 pm
Charisse Winston, Keck School of Medicine of USC
Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Other Age-Related Dementias

2:35 pm – 2:55 pm
Shajila Siricilla, VUMC
Identification of Therapeutics for Management of Preterm Birth

2:55 pm – 3:05 pm
Alexis Surtel, NIH
Neuroprotection in C. Elegans Parkinson's Disease Models: Discovering Therapeutic Insights via RNAi and Small Molecule High Throughput Screening

3:05 pm – 3:15 pm
Maaike Everts, Critical Path Institute
C-Path's Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development

3:15 pm – 3:35 pm | Sponsor Networking Break

Focus: The Start Defines the Project

3:35 pm – 3:40 pm | Introduction

3:40 pm – 4:45 pm | Sessions

3:40 pm – 4:00 pm
Barbara Slusher, JHMI and Diane Peters, JHMI
Development of a Gut-Restricted GCPII Inhibitor for Inflammatory Bowel Disease

4:00 pm – 4:40 pm | Keynote: Michelle Arkin, PhD, University of California, San Francisco
Linking Chemical Fragments and Connecting Across Cultures

4:40 pm – 4:45 pm | Closing Remarks

Registration

Registration here for the Colloquium.

Colloquium registration fees include access to all keynotes, scientific talks, and poster sessions as well as all food functions listed in the final Colloquium schedule.

 

ADVANCE
On or before 4/18/2024

FULL PRICE
On or after 4/19/2024

ADDC or ASPET Member $100$150
Non-member $200 $250
Trainees (student/postdoc) $50 $100

Partners

Interested in partnering with us? Review our ADDC-ASPET Colloquium Sponsorship Brochure to find out more. If you have additional questions, contact us at meetings@aspet.org.

Thank you to our sponsors!

SILVER LEVEL

Collaborative Drug Discovery (CDD Vault)

CDDVault Logo

Schrödinger, Inc.

 

Schrodinger Logo_Horizontal_Color_RGB

WuXi AppTec

 

WuXi Logo_bluetransparent

BRONZE LEVEL

  • Agilent Technologies
  • Chemveda Life Sciences
  • Cube Biotech Inc.
  • Johnson & Johnson
  • Life Chemicals Inc.
  • MedChemExpress LLC
  • Promega

SESSION SPONSOR

  • HiQScreen Sàrl

SUPPORTERS

  • Rothwell Figg
  • ASPET Division for Drug Discovery and Development
  • ASPET Partnerships Committee

Job Postings